Advancement in sequencing technology enables the study of association between complex disorders and rare variants with low minor allele frequencies. One of the major challenges in rare variant testing is lack of statistical power of traditional testing methods due to extremely low variances of single nucleotide polymorphisms. In this paper, we introduce a W-test collapsing method that evaluates the distributional differences in cases and controls using a combined log of odds ratio. The proposed method is compared with the Weighted-Sum Statistic and Sequence 2 Kernel Association Test using simulation data sets and showed better performances and faster computing speed. In the study of real next generation sequencing data set of hypertensive disorder, we identified genes of interesting biological functions that are associated to metabolism disorder and inflammation, which include the MACROD1, NLRP7, AGK, PAK6 and APBB1. The W-test collapsing method offers a fast, effective and alternative way for rare variants association analysis.
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Background
In the past decade, genetic association studies identified a repertoire of associated variants for complex disorders [1] . However, a large portion of the disease heritability remains unexplained.
Areas that may account for the missing heritability in complex traits include polygenetic effects, gene-environment interactions, and rare variants associations [2] . Sequencing technology development in recent years allow deep DNA sequencing to be done at lower cost, and the Next Generation Sequencing (NGS) is made available for studying extreme low frequency variants. One main challenge in studying rare variants association is the lack of statistical power due to low minor allele frequency (MAF). Furthermore, the high volume of genetic markers also increases the burden of multiple testing. A number of statistical methods for rare variant association testing have been proposed, which can be generally divided into two categories, the burden tests such as the Weighted Sum Statistic (WSS) [3] and Combined Multivariate Collapsing [4] ; and the variance component tests such as the C-alpha test [5] and the Sequence Kernel Association Test (SKAT) [6] . Both types of methods increase power for rare variants by defining larger genomic regions to conduct the test. In this paper, we introduce a W-test collapsing method to evaluate rare variant data. The method tests the distributional differences in cases and controls using a retrospective 3 design after collapsing the allele frequencies within a genomic region。 The test statistic carries an inherent Chi-squared distribution with data-set dependent degrees of freedom. Power and type I error rate of W-test collapsing is compared with the WSS and the SKAT using simulated data sets. The proposed method showed better performances and several hundred times faster in computing speed. The proposed method is also applied on real NGS data set of hypertensive disorder, and interesting genes have been found.
Method

The W-test
The W-test is formulated to test the distributional difference of a SNP in the affected from the unaffected group [7] . Suppose a variant X has k levels, and Y is binary. If a variant carries three genotypes, AA, Aa and aa, then k=3. The test takes the following form: 
where is the proportion of cases in cell-i out of total case number, and is the proportion of controls in cell-i out of total control number. SE i is the standard error of log odds ratio of cell-i, in which n 1i and n 0i are the number of cases and controls in the i th cell; N 1 and N 0 are the total number of cases and controls, respectively. The scalar h and the degrees of freedom parameter f are obtained by estimating the covariance matrix from the bootstrapped data under null hypothesis.
The statistic follows a Chi-squared distribution with f degrees of freedom. Empirical studies give . Five hundred replicated data sets are generated to calculate the power and type I error rate.
Power is the averaged true positive rates in 500 replicates, and type I error rate is the average false positive rates. A positive gene is defined as the gene which p-value is smaller than Bonferroni corrected alpha of 5% in 60 genes.
GAW18 simulated and real data sets
Both simulated and real data set from the Genetic Analysis Workshop 18 (GAW18) are applied. 
Results
Comparison of alternative methods in simulation data
In Scenario I where causal SNPs in a gene have the same effect direction, the W-test's power is 66.6%, slightly better than WSS's 66.3%. Both burden tests outperform the SKAT's power 55.9%
( 
Application to GAW18 simulation study
The ROC curves of the W-test, SKAT and the WSS are plotted in Figure 1 . The figure shows that in the GAW18 data set, all methods have low power and high false positive rates. showed that the W-test collapsing has slight power advantage than the SKAT and WSS in the GAW18 data; it also shares common properties of the other two distinct methods, and has unique finding of its own.
Application to real hypertension exome sequencing data
We applied the W-test collpasing method on real exome data of hypertensive disorder. [16, 17] . The acylglycero kinase (AGK) is involved in lipid and glycerolipid metabolism, and it was found to have a significant over expression in retinas of diabetic rats [18] , and may play a role in the development of cataract [19] . The gene PAK6 is a p21-activated kinase that is central to signal transduction and cellular regulation. Previous cellline, tissue and gene expression studies reported this gene may play essential roles in the initiation and progression of hepatocellular carcinoma [20, 21] . The protein encoded by APBB1 is a member of the Fe65 protein family, and interacts with the transcription factor LBP1 and the low-density lipoprotein receptor-related protein [22] .
Discussion
We propose a W-test collapsing method to test the association between a dichotomous phenotype and rare genetic variants. It is model-free, fast, and tests the distributional differences in cases and controls through the integrated log odds ratios. Because of the odds ratio design, it has a unique retrospective design that is suitable to be applied on both prospective and retrospective data sets.
The proposed method can be categorized as a burden test; therefore, it is more advantages under the scenario when the SNPs effect directions are the same, compared to variance component test.
It outperforms another burden test WSS under different effect scenarios. The advantage of the proposed method, apart from power and controlled type I error rate, is its p-value calculation free from large permutation. There are two major beneficial aspects: first is the extraordinary computing speed. Almost all rare variant tests heavily rely on Monte Carlo or permutations to calculate p-values. And the computing burden prohibits possible optimization of collapsing region in whole exome sequencing data. Second, the test inherits a dataset-dependent probability distribution. The proposed method uses small bootstrapped samples under null hypothesis to estimate refined degrees of freedom (non-integer) for the testing probability distribution. Because the estimation involves data covariance structure, the resulting chi-squared distribution can corrects for potential bias due to complex data structures and can give accurate p-value calculation at minimum computing cost.
We compared different methods at their optimized collapsing region on the GAW18 data set, which is usually not performed in the literature. The optimal bin size is related to the number of causal markers in the region, causal marker's effect sizes and directions, weighting scheme and the distribution of mutations in cases and controls. This study demonstrated that the optimal window sizes are not the same for different methods; and the best collapsing bin is smaller than the commonly adopted range, such as a gene or pathway [3, 6] . Further study is needed to explore how to locate the best collapsing region in real exome sequencing data.
In terms of identified causal regions in GAW18 data, the W-test collapsing method shared similarities with the WSS that they both identified the regions populated with many causal variants.
However, there are differences in the two burden methods: the WSS mainly found variants with moderate effect size, but the W-test collapsing identified large negative effect variants as well. The reason can be explained from the formulation of the two statistics. The WSS adds the number of mutated alleles in a genomic region and weight them inversely by the proportion of mutations in the unaffected subjects. A critical assumption of the WSS is that the minor alleles are mutations and contribute to disease risk [3] ; therefore, if the minor allele with protective effect are concentrated in the unaffected, the WSS will down weight the variants and could miss them. As a result, the causal gene SENP5 that contains 5 large negative effects SNPs is not short-listed by the WSS in the GAW18 simulation study, in which most of the mutations in this gene occur in the unaffected only once (Table 2) . On the contrary, the W-test collapsing does not make assumption on mutation effect; it directly tests the distributional differences between the affected and unaffected; therefore, it is more general than the WSS to identify protective effect rare variants.
The SKAT performs a kernel regression using variance component in each region, and variants with small MAF will be given heavier weights. The SKAT method tends to select a region that includes a few rare variants with large effect sizes, and it allows variants within a region to adopt opposite effect directions. In the GAW18 simulation study, four out of the five top regions identified by SKAT contain only 1 causal marker, and the rest gene ARHGEF3 contains 2 SNPs of same effect direction. Except for the first gene, the SKAT does not share common identified regions to the WSS and the W-test collapsing method. The rest variation in the causal marker distribution relates to the noise SNPs contained in collapsing region, and the random variations in the replication data sets. The simulation study showed that the proposed method has advantage in locating clustered causal rare variants, and is more general than the WSS to detect protective variants. Nevertheless, the three tests discussed in this study all have distinct properties and strength. In real data analysis, when the underlying genetic model is unknown, the methods may need to be considered jointly to obtain a complete picture. 
